NCT02954198View on ClinicalTrials.gov

Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 1, 2016

Primary Completion Date

December 27, 2018

Study Completion Date

December 27, 2018

Conditions
Immunosuppression
Interventions
DRUG

Tacrolimus

goal trough level 5-12ng/mL

DRUG

Prednisone

goal dose 5mg QD

DRUG

Mycophenolate mofetil

goal dose 1g BID

DRUG

Everolimus

goal trough level 3-8ng/mL

Trial Locations (1)

29425

Medical University of South Carolina, Charleston

All Listed Sponsors
lead

Medical University of South Carolina

OTHER

NCT02954198 - Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter